Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 7/20 | 0.54 |
| ▸ | BCHE | P06276 | 4/20 | 0.45 |
| ▸ | MAOB | P27338 | 3/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8321411 | 0.99 | TACR1 (0.55) | TACR1BCHEMAOBDRD2DRD4 | |
| SCHEMBL6994305 | 0.88 | TACR1 (0.49) | TACR1BCHESIGMAR1ACHE | |
| Hydrochloric Acid SCHEMBL27530914 | 0.86 | TACR1 (0.54) | TACR1BCHEMAOBGRIN1GRIN2B | |
| SCHEMBL734423 | 0.84 | TACR1 (0.58) | TACR1GRIN1GRIN2BSIGMAR1ACHE | |
| Hydrochloric Acid SCHEMBL28525106 | 0.83 | TACR1 (0.59) | TACR1GRIN1GRIN2BSIGMAR1ACHE | |
| SCHEMBL31230417 | 0.80 | TACR1 (0.53) | TACR1BCHEMAOBGRIN1GRIN2B | |
| SCHEMBL1339973 | 0.80 | TACR1 (0.53) | TACR1BCHEMAOBMCHR1GRIN1 | |
| SCHEMBL30994721 | 0.80 | TACR1 (0.53) | TACR1BCHEMAOBMCHR1GRIN1 | |
| SCHEMBL10869037 | 0.79 | DRD2 (0.50) | BCHEDRD2DRD4 | |
| Hydrochloric Acid SCHEMBL719130 | 0.79 | TACR1 (0.54) | TACR1BCHEMAOBMCHR1GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1025100-B1 | 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES, METHOD FOR PRODUCING THE SAME, AND THEIR USE | BASF AG (DE) | 2002-01-23 | — | — | EP | disclosed |
| EP-1140099-A1 | UTILISATION OF 2-SUBSTITUTED 1,2-BENZISOTHIAZOLE DERIVATIVES AND 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES FOR THE PROPHYLAXIS AND THERAPY OF CEREBRAL ISCHAEMIA | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-10 | — | — | EP | disclosed |
| EP-1025100-A1 | 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES, METHOD FOR PRODUCING THE SAME, AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-09 | — | — | EP | disclosed |
| WO-2000041697-A1 | UTILISATION OF 2-SUBSTITUTED 1,2-BENZISOTHIAZOLE DERIVATIVES AND 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES FOR THE PROPHYLAXIS AND THERAPY OF CEREBRAL ISCHAEMIA | BASF AKTIENGESELLSCHAFT (DE) | 2000-07-20 | — | — | WO | disclosed |
| WO-1999021857-A1 | 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES, METHOD FOR PRODUCING THE SAME, AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1999-05-06 | — | — | WO | disclosed |